GC Biopharma Market Cap

GC Biopharma has a market cap or net worth of 1.45 trillion as of May 30, 2025. Its market cap has increased by 11.29% in one year.

Market Cap

1.45T

Enterprise Value

2.63T

Revenue

1.71T

Ranking

n/a

PE Ratio

50.54

Stock Price

127,200.00

Market Cap Chart

Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.45T, an increase of 4,891.29%. That is a compound annual growth rate of 14.04%.

Market Cap History

Date	Market Cap	% Change
May 30, 2025	1,451.76B	-29.14%
Dec 30, 2024	2,048.67B	43.03%
Dec 28, 2023	1,432.35B	-3.09%
Dec 29, 2022	1,478.01B	-40.60%
Dec 30, 2021	2,488.07B	-46.31%
Dec 30, 2020	4,633.75B	206.42%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.45T
Celltrion	34.23T
ALTEOGEN	17.64T
Yuhan	7,815.64B
SK Biopharmaceuticals	7,283.13B
HLB Co., Ltd.	7,161.69B
Peptron	5,416.63B
PharmaResearch	4,685.73B

Market Cap Rankings